ro 32-0432 has been researched along with phorbol 12,13-dibutyrate in 2 studies
| Studies (ro 32-0432) | Trials (ro 32-0432) | Recent Studies (post-2010) (ro 32-0432) | Studies (phorbol 12,13-dibutyrate) | Trials (phorbol 12,13-dibutyrate) | Recent Studies (post-2010) (phorbol 12,13-dibutyrate) |
|---|---|---|---|---|---|
| 56 | 0 | 13 | 2,803 | 1 | 67 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birchall, AM; Bishop, J; Bradshaw, D; Cline, A; Coffey, J; Elliott, LH; Gibson, VM; Greenham, A; Hallam, TJ; Harris, W | 1 |
| Bibb, JA; Greene, RW; Hawasli, AH; Molkentin, JD; Sahin, B | 1 |
2 other study(ies) available for ro 32-0432 and phorbol 12,13-dibutyrate
| Article | Year |
|---|---|
Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation.
Topics: Administration, Oral; Amino Acid Sequence; Animals; Arthritis, Experimental; Female; Indoles; Lymphocyte Activation; Male; Mice; Molecular Sequence Data; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrroles; Rats; Rats, Inbred Lew; T-Lymphocytes | 1994 |
Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.
Topics: Animals; Cyclin-Dependent Kinase 5; Dopamine and cAMP-Regulated Phosphoprotein 32; Dose-Response Relationship, Drug; Immunoprecipitation; In Vitro Techniques; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phorbol 12,13-Dibutyrate; Phosphorylation; Protein Kinase C; Proteins; Pyrroles; Time Factors | 2008 |